| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
2 companies
Hochman David P serves as a See Remarks at OBIO and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 25 buys and 0 sells. Those positions are worth an estimated $2.6M at current prices.
Historically, Hochman David P's trades have earned a below-average insider score of 45/100 across 9 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -24.4%.
The biggest single holding is OBIO (~$2.5M) as See Remarks. Net of sales, the recent Form 4 record there shows accumulation of 83,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2015 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Buy | 1,000 | $1.92 | $1,919.20 | +0.2% |